Skip to main content
Michael Brundage MSc, FRCPC, MD
 Michael Brundage
Contact Info
613-533-6000 extension 78521

Faculty Bio

  • Director (Interim), Queen's Cancer Research Institute (July 1 2021 - Dec 31 2021)
  • Radiation Oncologist, Kingston Regional Cancer Centre
  • Co-director, Psycho-oncology Research Group of CCE 
  • Co-chair, The Quality of Life Committee of NCIC CTG
  • Professor, Department of Oncology, Queen's University
  • Professor, Department of Public Health Sciences, Queen's University


Dr. Brundage is a Radiation Oncologist and professor of Oncology, and in the Department of Public Health Sciences at Queen's University. While frequently interfacing with both the Canadian Cancer Trials Group (CCTG) and the clinical setting of the Department of Radiation Oncology at the Cancer Centre of Southeastern Ontario, Dr. Brundage's research program resides primarily within the Division of Cancer Care and Epidemiology at Queen's Cancer Research Institute, an applied research unit that he heads. Dr. Brundage has implemented the first Canadian Patterns of Care Study in prostate cancer radiotherapy. His work with psychologist Dr. Deb Feldman-Stewart addresses information provision and decision support for cancer patients. With regard to health-related quality of life (HRQL) and other patient reported outcomes (PROs), Dr. Brundage has worked to explore new methods of appropriately assessing and interpreting these outcomes in cancer clinical trials, as well as new ways of effectively communicating these outcomes to patients and clinicians.

Current Interests

  • Patterns of Care studies
  • Health services research in oncology
  • Knowledge translation
  • Quality of life and other patient-reported outcomes
  • Interventions to promote appropriate system performance, including workforce planning and peer review
  • Patient decision support


Dr. Brundage's publications are available on PubMed.